New York Blood Center

New York Blood Center

Founded in 1964 with backing from the Rockefeller family, New York Blood Center grew out of a public-health gap in New York’s Tri-State transfusion supply. Today it operates as a vertically integrated nonprofit that collects, tests, and distributes blood products while running a significant grant-funded research enterprise. The board is led by Chairman Howard P. Milstein, who has shaped the organization’s posture as both a medical utility and an endowment investor. The endowment’s portfolio spans buyout, distressed debt, late-stage expansion, fund-of-funds commitments, growth equity, and natural-resources strategies. Confirmed real-estate holdings include the Center East Life Sciences Hub at 310 East 67th Street in Manhattan, developed with Longfellow Real Estate Partners, and a multipurpose campus in Rye, New York. The geographic footprint centers on the Tri-State region, but the research collaborations and investment partnerships extend nationally, including operational ties with Blood Centers of America. In addition to its financial assets, NYBC Enterprises manages donor centers in the Bronx and operates the Honor Roll of Life program alongside the NYPD and FDNY — a community-partnership structure that deepens its donor base and provides predictable volume for the blood-supply chain. The team participates in key industry associations such as AABB, where it routinely sponsors programming and influences policy alongside other independent blood centers. The organization’s structural differentiator is a dual-operating posture rarely seen in nonprofit endowments: it is simultaneously a civic-facing blood utility and a multi-asset-class institutional investor. The real-property arm, developed in partnership with Longfellow Real Estate Partners, gives it an asset-heavy balance sheet that conventional grant-making foundations do not carry, positioning it to absorb cyclical pressure on donation-linked revenue.